SVN-001, SVN-002, SVN-015 and SVN-114 are investigational. None has been approved by any regulator, and their safety and efficacy have not been established. Nothing on this website is medical advice, an offer of securities or intended to promote any medicine. Forward-looking statements involve risks and uncertainties. Announcements made through a Regulatory Information Service (RNS) prevail over this website. Information is given as at 16 October 2026 unless stated otherwise. SPRAVATO® is a trademark of Johnson & Johnson.
Solvonis Therapeutics plc is registered in England and Wales, company number 10776788. Registered office: Eccleston Yards, 25 Eccleston Place, London SW1W 9NF.
